Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Hee Jun Kim"'
Autor:
Yong Sang Lee, Hojin Chang, Hang Seok Chang, Cheong Soo Park, Seok Mo Kim, Hee Jun Kim, Soo Young Kim
Publikováno v:
Asian Journal of Surgery. 44:1166-1171
Background/objective Open thyroidectomy has been the standard approach for patients undergoing thyroidectomy. However, this approach leads to prominent scars, hypesthesia, paresthesia, and uncomfortable sensations. We aimed to describe our modified t
Autor:
Jinhee Kim, Woong Ki Chung, Wonguen Jung, Seock-Ah Im, Tae Hyun Kim, Jeanny Kwon, In Ah Kim, Jae Sik Kim, Ki Mun Kang, Byung Ock Choi, Sea Won Lee, Kyung Hwan Shin, Yong Bae Kim, Won Sup Yoon, Hee Jun Kim, Kyung Su Kim, Kyubo Kim, Suzy Kim, Jee Suk Chang, Yeon Hee Park, Jihye Cha, Dae Yong Kim, Yoon Kyeong Oh, Jee Hyun Kim, Doo Ho Choi
Publikováno v:
Breast Cancer Research and Treatment. 186:453-462
To identify the risk factors leading to new brain metastases (BM) following brain-directed treatment for initial BM resulting from breast cancer (BC). In this multi-institutional study, 538 BC patients with available follow-up imaging after brain-dir
Autor:
Hyun Ae Jung, Ho Young Kim, Hyun Chang, Hunho Song, Se Hoon Park, Jung Hoon Kim, Jae Ho Byun, Byeong Seok Sohn, Inkeun Park, Kyung Hee Lee, Woo Kyun Bae, Chi Hoon Maeng, Seungtaek Lim, Jung A. Kim, Hyo Jin Lee, Do Hyoung Lim, Sung-min Kim, Hee Jun Kim
Publikováno v:
Cancer Medicine, Vol 8, Iss 12, Pp 5431-5437 (2019)
Cancer Medicine
Cancer Medicine
The regional lymph node‐positive bladder cancer was classified as stage IV in the AJCC 7th edition but was changed to stage IIIB in the 8th edition, revised in 2018. Among the various studies involving immune checkpoint inhibitors, groups that had
Autor:
Sooyoung Kim, Yong Sang Lee, Cheong Soo Park, Hang Seok Chang, Hyeok Jun Yun, Hee Jun Kim, Chi Young Lim
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundIBM’s Watson for Oncology (WFO) is an artificial intelligence tool that trains by acquiring data from the Memorial Sloan Kettering Cancer Center and learns from test cases and experts. This study aimed to analyze the adequacy and effectiv
Autor:
In Gyu Hwang, Jin Ho Hwang, Hee Jun Kim, Jae Chol Choi, Jin Hwa Choi, Joung Soon Jang, Su-Hyun Kim, Song Ee Park, Suk Won Park, Ju Won Seok
Publikováno v:
Journal of Cancer
Purpose: Acute kidney injury (AKI) affects cancer therapy outcome and increases morbidity and mortality in cancer patients. We investigated the incidence, risk factors, and clinical outcomes of AKI caused by palliative chemotherapy in lung cancer pat
Autor:
Ki Cheong Park, Hyeok Jun Yun, Hee Jun Kim, Hang Seok Chang, Ho Jin Chang, Jung Min Kim, Cheong Soo Park, Sang Yong Kim
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 536, p 536 (2021)
Volume 22
Issue 2
International Journal of Molecular Sciences, Vol 22, Iss 536, p 536 (2021)
Volume 22
Issue 2
Anaplastic thyroid cancer (ATC) is an undifferentiated and advanced form of thyroid cancer, accompanied with a high ratio of epigenetic adjustment, which occurs more than genetic mutations. In this study, we aimed to evaluate the synergistic anticanc
Autor:
Kyung Hae Jung, Ho Suk Oh, Keon Uk Park, Kyong Hwa Park, Jin-Hee Ahn, Yoon Ji Choi, Jae Hong Seo, Jinho Yoo, Ho Young Kim, In Sil Choi, Suee Lee, Soohyeon Lee, Seok Yun Kang, Ju Won Kim, Hye Sook Kim, Kyung Hun Lee, Kyung Eun Lee, In Hae Park, Hee Jun Kim, Yeon Hee Park
Publikováno v:
Cytokine. 142
Advanced breast cancer frequently metastasizes to the skeleton causing major mobility issues and hazards to quality of life. To manage osteolytic bone metastasis, bone-modifying agents and chemotherapy are recommended as the standard of care. Here, w
Autor:
Yong Sang Lee, Cheong Soo Park, Hee Jun Kim, Seok Mo Kim, Hojin Chang, Soo Young Kim, Hang Seok Chang, Soon Sun Kwon, Young-Jin Kim, Hyunjung Shin
Publikováno v:
Medicine
Although papillary thyroid cancers are known to have a relatively low risk of recurrence, several factors are associated with a higher risk of recurrence, such as extrathyroidal extension, nodal metastasis, and BRAF gene mutation. However, predicting
Autor:
Yoon Ji Choi, Hanjong Ahn, Hee Jun Kim, Kyong Hwa Park, Ho Yeong Lim, Kyung Hee Lee, Shinkyo Yoon, Jun Hyuk Hong, Inkeun Park, Bong Seog Kim, Hyo Jin Lee, Jae-Lyun Lee, Bumsik Hong
Publikováno v:
European journal of cancer (Oxford, England : 1990). 127
Purpose Gemcitabine–oxaliplatin (GEMOX) demonstrated mild toxicity and promising effectiveness in patients with advanced urothelial cell cancer (UCC). We investigated the activity and safety of first-line GEMOX compared with gemcitabine–carboplat
Autor:
Kyoung Eun Lee, Seock-Ah Im, Moon Hee Lee, Jee Hyun Kim, Jong In Lee, Soohyeon Lee, Hee Kyung Ahn, Han Jo Kim, Hee Jun Kim, Yeon Hee Park, Gun Min Kim, Seok Yun Kang, Kyung Hae Jung, Su Jin Koh, In Hae Park
Publikováno v:
Cancers
Volume 12
Issue 11
Cancers, Vol 12, Iss 3265, p 3265 (2020)
Volume 12
Issue 11
Cancers, Vol 12, Iss 3265, p 3265 (2020)
In the era of CDK4/6 inhibitors in hormone receptor (HR)-positive, HER2-negative metastatic breast cancer, few trials have been specifically studied to compare quality of life between palbociclib plus endocrine therapy (ET) and cytotoxic chemotherapy